Postmenopausal hormone therapy: the pros and cons

L. M. Rivera-Woll, S. R. Davis

Research output: Contribution to journalReview ArticleResearchpeer-review

3 Citations (Scopus)


The use of postmenopausal hormone therapy (HT) has recently generated much debate following the results of various large randomised controlled trials. This has challenged physicians to reassess the use of HT in each individual woman within the realm of her symptomatology and risk profile for long-term illnesses. There are several areas of definite benefit or risk and many areas of uncertainty. The results of recent randomised controlled trials pertain to the specific HT regimens used and the characteristics of the study groups, such that the conclusions cannot be extrapolated to the use of HT in general.

Original languageEnglish
Pages (from-to)109-114
Number of pages6
JournalInternal Medicine Journal
Issue number3
Publication statusPublished - Mar 2004


  • Hormone therapy
  • Menopause
  • Risk versus benefit

Cite this